| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 02/02/2011 | CN1899615B Preparation for the prophylaxis of restenose |
| 02/02/2011 | CN101965352A Pyripyropene derivative having acat2-inhibiting activity |
| 02/02/2011 | CN101965339A Novel catechol derivative, pharmaceutical composition containing the same, use of the catechol derivative, and use of the pharmaceutical composition |
| 02/02/2011 | CN101965196A Sugar chain-related gene and use thereof |
| 02/02/2011 | CN101961462A Chinese medicinal composition for resisting heat stress of pigeons and application thereof |
| 02/02/2011 | CN101961460A Chinese medicinal health-care composition and preparation method thereof |
| 02/02/2011 | CN101961447A Novel preparation method, preparation and application of Chinese medicinal composition |
| 02/02/2011 | CN101961437A Anti-stress compound preparation and preparation process thereof |
| 02/02/2011 | CN101961330A Anti-stress agent for aquatic livestock |
| 02/02/2011 | CN101475576B Flavone lignose compound, and preparation and pharmaceutical use thereof |
| 02/01/2011 | US7880020 Carbamic acid compounds comprising an amide linkage as HDAC inhibitors |
| 02/01/2011 | US7880009 Cinnamide compound |
| 02/01/2011 | US7879899 Injectable veterinary composition for small animals |
| 02/01/2011 | US7879874 3(R)-1-Phenethyl-(9[H]-xanthene-9-carbonyloxy)-1-azoniabicyclo[2.2.2] octane quaternary salt with a mono- or polyvalent anion; antimuscarinic agents used to treat chronic obstructive pulmonary disease, chronic bronchitis, bronchial hyperreactivity, asthma, or rhinitis |
| 02/01/2011 | US7879865 central nervous system disorders; brain cancer; oral administration |
| 02/01/2011 | US7879863 Aniline derivatives |
| 02/01/2011 | US7879843 Benzothiazin-3-one compound and intermediate therefor |
| 02/01/2011 | US7879832 Use of the combination of ciclesonide and antihistamines for the treatment of allergic rhinitis |
| 02/01/2011 | US7879831 Enhanced drug delivery in transdermal systems |
| 02/01/2011 | US7879811 Formulations comprising antisense nucleotides to connexins |
| 02/01/2011 | US7879810 That contain unmethylated cytosine-guanine (CpG) dinucleotides; stimulate an immune response and to redirect a Th2 response to a Th1 response; use with vaccines |
| 02/01/2011 | US7879609 Regulatory segments of the human gene for telomerase reverse transcriptase |
| 02/01/2011 | US7879547 Method of detecting the presence of asthma or allergies in a patient |
| 02/01/2011 | US7879366 Halogenated composition, method for preparing same and uses thereof |
| 02/01/2011 | US7879334 Bifunctional fusion protein capable of binding to a immunoglobulin inhibitory receptor comprising an immune receptor tyrosine-based inhibitory motif (ITIM), expressed on mast cells, basophils or B cells for use in treatment of allergic disorders |
| 02/01/2011 | US7879324 Using Fc epsilon R specific immunoglobulin fusion to treat and/or prevent type I hypersensitivity reaction |
| 02/01/2011 | US7879323 Antibodies to fibroblast growth factor-like polypeptides |
| 02/01/2011 | US7879315 such as inositol phosphoric acid esters (phytic acid), polyphenols (Perilla frutescen var. crispa polyphenols), perilla extract comprising rosmarinic acid, phosphoric acids, edetic acid salts, tartaric acid, malic acid, citric acid, and glycolic acid |
| 02/01/2011 | CA2551529C Amide derivative and medicine |
| 02/01/2011 | CA2494091C Substituted furo [2,3-b| pyridine derivatives |
| 02/01/2011 | CA2490896C Antiallergic agent, utilization thereof for reducing allergy and method of reducing allergy |
| 02/01/2011 | CA2484935C Amide derivatives as inhibitors of the enzymatic activity of renin |
| 02/01/2011 | CA2483110C Use of a mare milk concentrate dried on a biologically inert, highly disperse matrix |
| 02/01/2011 | CA2481468C Medicaments containing betamimetic drugs and a novel anticholinesterase drug |
| 02/01/2011 | CA2481055C Combinations of quinolinone derivatives and 5-fu or cpt 11 |
| 02/01/2011 | CA2477881C Formoterol superfine formulation |
| 02/01/2011 | CA2476298C Carbocyclic and oxacarbocyclic fumaric acid oligomers |
| 02/01/2011 | CA2466140C Novel 1,2,4-thiadiazole derivatives as melanocortin receptor modulators |
| 02/01/2011 | CA2461218C Muscarinic agonists |
| 02/01/2011 | CA2459449C Benzothiazepine and benzothiadiazepine derivatives with ileal bile acid transport (ibat) inhibitory activity for the treatment hyperlipidaemia |
| 02/01/2011 | CA2453747C Substituted 2-thio-3,5-dicyano-4-phenyl-6-aminopyridines and their use |
| 02/01/2011 | CA2453442C Compositions and methods of administering tubulin binding agents for the treatment of ocular diseases |
| 02/01/2011 | CA2447878C 5-chloro-3-(4-methanesulfonylphenyl)-6'-methyl-[2,3']bipyridinyl in pure crystalline form and process for synthesis |
| 02/01/2011 | CA2442917C Combination therapy comprising glucose reabsorption inhibitors and ppar modulators |
| 02/01/2011 | CA2430755C Method of producing a partial or complete active ingredient coating on and in implants and onplants |
| 02/01/2011 | CA2418656C Proline derivatives and use thereof as drugs |
| 02/01/2011 | CA2406212C Substituted styryl benzylsulfones for treating proliferative disorders |
| 02/01/2011 | CA2388377C Medication for the treatment of chronic fatigue syndrome and related symptoms |
| 02/01/2011 | CA2382887C Immunopotentiating compositions |
| 02/01/2011 | CA2320116C 2-aminoquinoline derivatives having d4-agonistic activity |
| 02/01/2011 | CA2315717C Inhibition of raf kinase using substituted heterocyclic ureas |
| 02/01/2011 | CA2315713C Inhibition of raf kinase using aryl and heteroaryl substituted heterocyclic ureas |
| 02/01/2011 | CA2313653C Prevention and/or treatment of allergic conditions |
| 02/01/2011 | CA2125472C A method for generation of antibodies to cell surface molecules |
| 02/01/2011 | CA1341610C Osteogenic polypeptides |
| 01/27/2011 | WO2011010848A2 Multifunctional nanoparticles for fluorescence, mr and pet images comprising magnetic silica nanoparticles doped with a near-infrared (nir) dye allowing composite imaging of lymph nodes and deep organs, and a method for synthesising the same |
| 01/27/2011 | WO2011010715A1 Pr-set7 inhibitor |
| 01/27/2011 | WO2011010706A1 Fgf21 cis-element binding substance |
| 01/27/2011 | WO2011010682A1 Sterol derivative |
| 01/27/2011 | WO2011010678A1 Polyphenol-containing composition for oral administration or external use and use of same |
| 01/27/2011 | WO2011010456A1 EXTERNAL PREPARATION CONTAINING NSAIDs AND METHOD FOR PRODUCING THE EXTERNAL PREPARATION |
| 01/27/2011 | WO2011010399A1 Corneal endothelial cell proliferation promoter |
| 01/27/2011 | WO2011009760A1 Use of an active substance of echinacea to influence the natural pigmentation process |
| 01/27/2011 | US20110023149 Genomic editing of genes involved in tumor suppression in animals |
| 01/27/2011 | US20110023144 Genomic editing of genes involved in amyotrophyic lateral sclerosis disease |
| 01/27/2011 | US20110023139 Genomic editing of genes involved in cardiovascular disease |
| 01/27/2011 | US20110021766 Epimerized derivatives of k5 polysaccharide with a very high degree of sulfation |
| 01/27/2011 | US20110021638 Modulation of inflammation by hops fractions and derivatives |
| 01/27/2011 | US20110021632 Use of creatine or creatine compounds for skin preservation |
| 01/27/2011 | US20110021612 Nk1 fragment of hepatocyte growth factor/scatter factor (hgf/sf) and variants thereof, and their use |
| 01/27/2011 | US20110021610 Aromatic prenyltransferase from hop |
| 01/27/2011 | US20110021608 Methods for nucleic acid transfer into cells |
| 01/27/2011 | US20110021605 Means and methods for the specific inhibition of genes in cells and tissue of the cns and/or eye |
| 01/27/2011 | US20110021603 TRPM-2 Antisense Therapy |
| 01/27/2011 | US20110021508 Methods for Alzheimer's Disease Treatment and Cognitive Enhancement |
| 01/27/2011 | US20110021462 Substituted tetrahydro-2h-isoquinolin-1-one derivatives, and methods for the production and use thereof |
| 01/27/2011 | US20110021461 Combinations to improve animal health and performance |
| 01/27/2011 | US20110021438 Novel compounds of the n-acylamino-amide family, compositions comprising them and uses thereof |
| 01/27/2011 | US20110021413 Methods of suppressing microglial activation |
| 01/27/2011 | US20110020928 Immunovectors which can be used for the intracellular and intranuclear transport |
| 01/27/2011 | US20110020901 Methods of Making Viral Particles Having a Modified Cell Binding Activity and Uses Thereof |
| 01/27/2011 | US20110020464 Methods of treatment using thymus-derived compositions |
| 01/27/2011 | US20110020452 Progenitor cell replication and differentiation in 3d |
| 01/27/2011 | US20110020432 Compositions and methods of use for post-radiation protection |
| 01/27/2011 | US20110020400 Probiotic bifidobacterium strains |
| 01/27/2011 | US20110020351 Novel polypeptide esdn, polynucleotides encoding the polypeptide, and utility of the polypeptide |
| 01/27/2011 | US20110020324 Compound capable of binding s1p receptor and pharmaceutical use thereof |
| 01/27/2011 | US20110020292 Use of Stem Cells to Reduce Leukocyte Extravasation |
| 01/27/2011 | US20110020280 Pharmaceutical composition for transnasal administration |
| 01/27/2011 | US20110020271 Elastin for soft tissue augmentation |
| 01/27/2011 | US20110020243 Methods and compositions for imaging cancer cells |
| 01/27/2011 | US20110020240 Use of bacterial beta-lactamase for in vitro diagnostics and in vivo imaging, diagnostics and therapeutics |
| 01/27/2011 | US20110020234 Rna interference mediating small rna molecules |
| 01/27/2011 | US20110020229 Multi-Component Biological Transport Systems |
| 01/26/2011 | EP2278004A1 RNA interference mediated inhibition of gene expression using short interfering nucleic acid (siNA) |
| 01/26/2011 | EP2277920A2 Inhibitors of complement activation |
| 01/26/2011 | EP2277919A1 Treatment with anti-ERBB2 antibodies |
| 01/26/2011 | EP2277914A2 Antigen binding domains from fish |
| 01/26/2011 | EP2277913A2 Antigen binding domains from fish |
| 01/26/2011 | EP2277900A1 Metastin derivative and use thereof |